• 1
    Bitnum S, Daeschner CW Jr, Travis LB, Dodge WF, Hopps HC. Dermatomyositis. J Pediatr 1964; 64: 10131.
  • 2
    Sanner H, Gran JT, Sjaastad I, Flato B. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford) 2009; 48: 15417.
  • 3
    Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010; 62: 6372.
  • 4
    Apaz MT, Saad-Magalhaes C, Pistorio A, Ravelli A, de Oliveira Sato J, Marcantoni MB, et al, for the Paediatric Rheumatology International Trials Organisation. Health-related quality of life of patients with juvenile dermatomyositis: results from the Paediatric Rheumatology International Trials Organisation Multinational Quality of Life cohort study. Arthritis Rheum 2009; 61: 50917.
  • 5
    Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43: 5419.
  • 6
    Archenholtz B, Nordborg E, Bremell T. Lower level of education in young adults with arthritis starting in the early adulthood. Scand J Rheumatol 2001; 30: 3535.
  • 7
    Eberhardt K, Larsson BM, Nived K. Early rheumatoid arthritis: some social, economical, and psychological aspects. Scand J Rheumatol 1993; 22: 11923.
  • 8
    Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 2003; 48: 76775.
  • 9
    Huber A, Feldman BM. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Curr Rheumatol Rep 2005; 7: 4416.
  • 10
    Burckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 2003; 1: 60.
  • 11
    Ferrans CE. Development of a quality of life index for patients with cancer. Oncol Nurs Forum 1990; 17 Suppl: 159.
  • 12
    WHO. International Classification of Functioning, Disability and Health (ICF). 2001. URL:
  • 13
    Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 3447.
  • 14
    Burckhardt CS, Woods SL, Schultz AA, Ziebarth DM. Quality of life of adults with chronic illness: a psychometric study. Res Nurs Health 1989; 12: 34754.
  • 15
    Burckhardt CS, Anderson KL, Archenholtz B, Hagg O. The Flanagan Quality Of Life Scale: evidence of construct validity. Health Qual Life Outcomes 2003; 1: 59.
  • 16
    Flanagan JC. A research approach to improving our quality of life. Am Psychol 1978; 32: 13847.
  • 17
    Wahl AK, Rustoen T, Hanestad BR, Lerdal A, Moum T. Quality of life in the general Norwegian population, measured by the Quality of Life Scale (QOLS-N). Qual Life Res 2004; 13: 10019.
  • 18
    Burckhardt CS, Archenholtz B, Bjelle A. Quality of life of women with systemic lupus erythematosus: a comparison with women with rheumatoid arthritis. J Rheumatol 1993; 20: 97781.
  • 19
    Liedberg GM, Burckhardt CS, Henriksson CM. Validity and reliability testing of the Quality of Life Scale, Swedish version in women with fibromyalgia: statistical analyses. Scand J Caring Sci 2005; 19: 6470.
  • 20
    Wahl A, Burckhardt C, Wiklund I, Hanestad BR. The Norwegian version of the Quality of Life Scale (QOLS-N): a validation and reliability study in patients suffering from psoriasis. Scand J Caring Sci 1998; 12: 21522.
  • 21
    Ware JE, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: New England Medical Center; 2005.
  • 22
    Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 health survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998; 51: 107786.
  • 23
    Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 health survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998; 51: 106976.
  • 24
    Loge JH, Kaasa S. Short Form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998; 26: 2508.
  • 25
    Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al, for the International Myositis Outcome Assessment Collaborative Study Group. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001; 40: 126273.
  • 26
    Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease Activity Score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003; 49: 715.
  • 27
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 28
    Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004; 43: 4954.
  • 29
    Ostlie IL, Johansson I, Moller A. Struggle and adjustment to an insecure everyday life and an unpredictable life course: living with juvenile idiopathic arthritis from childhood to adult life. An interview study. Disabil Rehabil 2009; 31: 66674.
  • 30
    Sanner H, Kirkhus E, Merckoll E, Tollisen A, Roisland M, Lie BA, et al. Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case–control study. Arthritis Care Res (Hoboken) 2010; 62: 110311.
  • 31
    Rapkin BD, Schwartz CE. Toward a theoretical model of quality-of-life appraisal: implications of findings from studies of response shift. Health Qual Life Outcomes 2004; 2: 14.
  • 32
    Schwartz CE, Andresen EM, Nosek MA, Krahn GL. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 2007; 88: 52936.
  • 33
    Prouty D, Ward-Smith P, Hutto CJ. The lived experience of adult survivors of childhood cancer. J Pediatr Oncol Nurs 2006; 23: 14351.
  • 34
    Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC. An evaluation of a psychosocial intervention for survivors of childhood cancer: paradoxical effects of response shift over time. Psychooncology 1999; 8: 34454.
  • 35
    Wahl AK, Rustoen T, Hanestad BR, Gjengedal E, Moum T. Living with cystic fibrosis: impact on global quality of life. Heart Lung 2005; 34: 32431.
  • 36
    Olsson I, Campenhausen G. Social adjustment in young adults with absence epilepsies. Epilepsia 1993; 34: 84651.
  • 37
    Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employment. Rheumatology (Oxford) 2002; 41: 14369.